| Literature DB >> 27585638 |
Bipin Kumar Gupta1, Satbir Singh1,2, Pawan Kumar1,2, Yean Lee3, Garima Kedawat4, Tharangattu N Narayanan5, Sajna Antony Vithayathil6, Liehui Ge3, Xiaobo Zhan3, Sarika Gupta7, Angel A Martí8, Robert Vajtai3, Pulickel M Ajayan3, Benny Abraham Kaipparettu6,9.
Abstract
Nanoparticles exhibiting both magnetic and luminescent properties are need of the hour for many biological applications. A single compound exhibiting this combination of properties is uncommon. Herein, we report a strategy to synthesize a bifunctional luminomagnetic Gd2-xEuxO3 (x = 0.05 to 0.5) nanorod, with a diameter of ~20 nm and length in ~0.6 μm, using hydrothermal method. Gd2O3:Eu(3+) nanorods have been characterized by studying its structural, optical and magnetic properties. The advantage offered by photoluminescent imaging with Gd2O3:Eu(3+) nanorods is that this ultrafine nanorod material exhibits hypersensitive intense red emission (610 nm) with good brightness (quantum yield more than 90%), which is an essential parameter for high-contrast bioimaging, especially for overcoming auto fluorescent background. The utility of luminomagnetic nanorods for biological applications in high-contrast cell imaging capability and cell toxicity to image two human breast cancer cell lines T47D and MDA-MB-231 are also evaluated. Additionally, to understand the significance of shape of the nanostructure, the photoluminescence and paramagnetic characteristic of Gd2O3:Eu(3+) nanorods were compared with the spherical nanoparticles of Gd2O3:Eu(3+).Entities:
Mesh:
Substances:
Year: 2016 PMID: 27585638 PMCID: PMC5009349 DOI: 10.1038/srep32401
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(a) XRD pattern of as-synthesized Gd0.925Eu0.075(OH)3 nanophosphor; left inset represents the as-synthesized luminescent powder sample under excitation of 254 nm and right inset exhibits the structure of Gd0.925Eu0.075(OH)3 nanophosphor. (b) XRD pattern of as-synthesized Gd1.85Eu0.15O3 nanorods; left inset represents the as-synthesized luminescent powder sample under excitation of 254 nm and right inset exhibits the structure of Gd1.85Eu0.15O3 nanorods. (c) SEM image of as-synthesized Gd0.925Eu0.075(OH)3 nanophosphor. (d) Magnified view of Fig. c. (e) SEM image of as-synthesized Gd1.85Eu0.15O3 nanorods. (f) Magnified view of Fig. e.
Figure 2(a) TEM image of as-synthesized Gd0.925Eu0.075(OH)3 nanophosphor. (b) Magnified view of Fig. (a) (c) HRTEM image of as-synthesized Gd0.925Eu0.075(OH)3 nanophosphor. (d) TEM image of as-synthesized Gd1.85Eu0.15O3 nanorods. (e) Magnified view of Fig. (d). (f) HRTEM image of as-synthesized Gd1.85Eu0.15O3 nanorods.
Figure 3(a) PL emission spectrum of as-synthesized Gd1.85Eu0.15 O3 nanorods recorded at 252 nm excitation showing a sharp, intense, hypersensitive red emission peak with maximum at 610 nm (5D0 – 7F2) at room temperature; left inset shows typical photographs of as-synthesized Gd2O3:Eu3+ nanorods sample in DI-water under room light as well as a 252 nm UV lamp (a strong red emission of Eu3+ is observed under UV excitation) and the right inset shows the color coordinates x = 0.6574 and y = 0.3424. (b) TRPL decay profile of as-synthesized Gd1.85Eu0.15O3 nanorods recorded at room temperature while monitoring the emission at 610 nm at an excitation wavelength of 252 nm; inset shows the lifetime data and the parameter generated by the exponential fitting. (c) Room-temperature M-H curve of as-synthesized Gd2O3:Eu3+ nanoparticles, Gd(OH)3:Eu3+ nanophosphor and Gd2O3:Eu3+ nanorods; photographs of luminomagnetic as-synthesized Gd1.85Eu0.15O3 nanorods in glass vials i) without and ii) with an external permanent magnet (≈3000 Oe) are shown in inset. (d) Magnetic tracking of luminomagnetic as-synthesized Gd1.85Eu0.15O3 nanorods in an aqueous dispersion showing sequential photographs as a function of time under ambient as well as UV light (252 nm) with external permanent magnet (≈4000 Oe).
Figure 4Cell viability assay with human breast cancer cell lines, (a) T47D and (b) MDA-MB-231 incubated with different concentrations of Gd1.85Eu0.15O3 nanorods. Anticancer drug Taxol was used as a positive control for cytotoxicity assays. The percentage of cells are calculated relative to the dilution medium treated cells at 24 hours.
Figure 5In vitro fluorescence microscopy images of T47D cells incubated with Gd1.85Eu0.15O3 nanorods (5 μg mL−1) for 4 h.
Sequential images of single cell (i–v) and cell cluster (vi–x) show: i) Phase contrast image. ii) Nuclear staining with DAPI. iii) Red fluorescence from Gd1.85Eu0.15O3 nanorods. iv) Overlapped images of blue DAPI and red Gd1.85Eu0.15O3 nanorods (ii and iii). v) Overlap of phase contrast, blue, and red, from (i–iii), respectively. A similar imaging pattern presented for cell cluster with vi) Phase contrast image. vii) Nuclear staining with DAPI. viii) Red fluorescence from Gd1.85Eu0.15O3 nanorods. ix) Overlapped images of blue DAPI and red Gd1.85Eu0.15O3 nanorods (vii and viii). x) Overlap of phase contrast, blue, and red, from (vi–viii), respectively.